Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies

BACKGROUND: We aimed to evaluate the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy (hypo-RT) in atypical histologic subtypes of primary and metastatic mediastinal malignancies. METHODS: Fifty-four patients diagnosed with atypical primary or met...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, FanJun, Ai, XinLei, Wang, Bin, Zhou, Yin, Li, Su, Wang, DaQuan, Liu, FangJie, Chen, NaiBin, Zhou, Rui, Guo, JinYu, Huang, XiaoYan, Yin, ShaoHan, Qiu, Bo, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585306/
https://www.ncbi.nlm.nih.gov/pubmed/36276120
http://dx.doi.org/10.3389/fonc.2022.974394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585306/
https://www.ncbi.nlm.nih.gov/pubmed/36276120
http://dx.doi.org/10.3389/fonc.2022.974394

Ejemplares similares